Defining Excellence in Cardiac Care: HeartSync’s PMA Journey

In July of 2023, after much time, effort and expense, Nissha Medical Technologies (NMT) was awarded PMA approval from the Food and Drug Administration (FDA) for its HeartSync line of disposable defibrillation electrodes. This signaled the culmination of successful efforts by many people inside and outside of the organization and further reinforces NMT as a world-renowned manufacturer of disposable electrodes.

How NMT Redefines Innovation In Healthcare

Our world is constantly in flux, and the medical device industry is no exception. Frequent disruptions to our workflow demand flexibility, agility, and a solution-oriented mindset to stay on track and achieve our corporate goals. Fortunately, we have the power to focus on high-potential areas within our control.

Breakthrough in Kidney Stone Treatment: Nissha and EndoTheia Unveil FlexStone™ Basket